X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank20
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.14
↓ 43% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
-1.49
Historical baseline
PeriodValueYoY Change
2025-2.14+45.8%
2024-3.94-167.2%
2023-1.47-119.3%
2022-0.67-1.1%
2021-0.66+68.0%
2020-2.08+11.1%
2019-2.34-7205.3%
2018-0.03+75.3%
2017-0.13+91.1%
2016-1.45-